Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Acquisition Update

15 Aug 2011 07:00

RNS Number : 3288M
Silvermere Energy PLC
15 August 2011
 



15 August 2011

 

Silvermere Energy plc

("Silvermere" or "the Company")

 

Acquisition Update

 

In the admission document published by the Company on 2 August 2011 ("the Admission Document"), the Company stated that, conditional on the grant of shareholder approval at a general meeting which is scheduled to take place on 18 August 2011, it intended to exercise its option to acquire the Mustang Asset and to seek readmission for the Company's shares to trading on AIM.

 

Definitions used in this announcement are as set out in the Admission Document.

 

The consideration for the acquisition of the Mustang Asset from Core Petroleum, Inc ("Core") as set out in the Option Agreement was stated as follows:

 

·; Cancellation of the debt due from Core to Silvermere (which amounts to £2.595 million);

·; Payment of certain of Core's legal fees amounting to £20,000;

·; Payment to the vendors of an over-riding royalty of 4 per cent. of the annual revenues attributable to 100 per cent. of the Mustang Asset;

·; Retention by Core of a 16.65 per cent. working interest in the I-1 Well only with the Company carrying Core's share of the tie-in costs; and

·; The issue at admission of the Company's shares to trading on AIM ("Admission") of the 676,000 shares to the vendors (this will be effected by a payment by the Company to the vendors of £169,000, which they will use to subscribe for the shares).

 

Thus the total effective consideration payable by Silvermere at Admission is £2.8 million. The amount of on-going royalties payable by Silvermere will depend on production and revenue from the Mustang Asset.

 

Following to the publication of the Admission Document, Core has informed the Company that it has received an additional cash call under the JOA relating to a cost overrun on the re-entry of the I-1 Well during the six month period ended 30 June 2011 ("the Cash Call"). The cash call amounts to approximately £250,000 which is material in relation to the Company's expected expenditure on the Mustang Asset and the Company's future working capital requirements.

 

Under the terms of the Option Agreement, Silvermere is responsible for additional costs incurred in relation to the re-entry of the I-1 Well. If the Company exercises its option to acquire the Mustang Asset, the Company will be required to pay Core's proportion of the Cash Call and, therefore, Silvermere will have increased the consideration paid for the Mustang Asset by the corresponding amount.

 

Following receipt of notification of the Cash Call by the Core Vendors, Silvermere entered into substantive discussions with Core and Dominion and the Directors and the Proposed Directors are confident that an outcome can be reached which will result in the aggregate amount of the consideration payable by Silvermere being maintained in accordance with the Admission Document and the Company's working capital requirement for the foreseeable future (being at least 12 months). Until such discussions are concluded, however, there can be no certainty that such an outcome can be achieved.

 

As a result, the Chairman of the Directors of Silvermere, Bruce Evers intends to request that the general meeting of the Company to be held on 18 August 2011 is adjourned until 30 August 2011. The Company will make a further announcement following the general meeting.

 

Since the Option Agreement expires on 19 August 2011, the Company and the Core Vendors have agreed to extend the option agreement to expire on 9 September 2011.

 

A further announcement will be made prior to the general meeting.

 

ENDS

 

For further information please contact:

 

Silvermere Energy plc

Frank Moxon, Proposed Chairman

Andy Morrison, Proposed Chief Executive

Bruce Evers, Current Executive Chairman

 

 

 

 

+44 (0)1379 640 800

+44 (0)7980 878561

+44 (0)7779 138 471

Merchant Securities Limited (Nominated Adviser and Broker)

Lindsay Mair/Virginia Bull

 

Rivington Street Corporate Finance Limited

Jon Levinson/Dru Edmonstone

 

Old Park Lane Capital

Luca Tenuta

 

 

+ 44(0)20 7628 2200 

 

 

+44 (0)20 7562 3357

 

+44 (0)20 7493 8188

Bishopgate Communications

Nick Rome/Shabnam Bashir

 

+44(0)20 7562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDZLFFFVFLBBB
Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.